Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 20'th Jun 2025
NOVATO, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rar
NaaS Technology Inc. Received Nasdaq Notification Regarding Minimum Market Value Deficiency
04:20pm, Friday, 20'th Jun 2025
BEIJING , June 20, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that it has received
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 20'th Jun 2025
WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader
Marin Software Incorporated Receives Nasdaq Notification Regarding Delisting From Nasdaq
04:10pm, Friday, 20'th Jun 2025
SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marin Software Incorporated (NASDAQ: MRIN) (“Marin,” “we,” “our,” or the “Company”), a provider of digital marketing software for performance-dr
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
03:19pm, Friday, 20'th Jun 2025
PITTSBURGH, June 20, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
11:30am, Friday, 20'th Jun 2025
SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on
This Nasdaq ETF Could Turn $500 Monthly Into $1 Million
10:00am, Friday, 20'th Jun 2025
The $1 million mark is a significant financial milestone for many people. There's something about seven figures that feels like you have achieved a real level of financial security.
Dot Ai, Innovator in Asset Intelligence Technology, Completes Business Combination; Will Begin Trading on Nasdaq Stock Market
07:00am, Friday, 20'th Jun 2025
LAS VEGAS & KENNESAW, Ga.--(BUSINESS WIRE)--Dot Ai, Innovator in Asset Intelligence Technology, Completes Business Combination; Will Begin Trading on Nasdaq Stock Market.
Here's How Much a $30,000 Investment in the Nasdaq 100 Today Could Be Worth in 30 Years
06:30am, Friday, 20'th Jun 2025
Growth stocks can generate returns far superior to those of value stocks or dividend stocks in the long run. These are the types of companies that investors are drawn to because if they're growing, th
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Thursday, 19'th Jun 2025
FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June
History Says the Nasdaq Will Soar: 1 Brilliant AI Stock to Buy Now, According to Wall Street
03:12am, Thursday, 19'th Jun 2025
Earlier this year, the Nasdaq Composite (^IXIC 0.13%) dropped into market correction territory as investors reacted to the prospect of sweeping tariffs. However, the index has historically rebounded s
Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut
04:01pm, Wednesday, 18'th Jun 2025
On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq's opening bell in New York, marking the company's awaited initial public offering.
Slide Insurance IPO: Stock price will be closely watched today as insurtech firm debuts on the Nasdaq
03:01pm, Wednesday, 18'th Jun 2025
Slide Insurance Holdings is set to debut on the Nasdaq today. The residential insurance company out of Florida will make its initial public offering for $17 per share.
Hoth Therapeutics Regains Nasdaq Compliance - Clears Key Listing Hurdle, Reaffirms Path Toward Growth
01:34pm, Wednesday, 18'th Jun 2025
NEW YORK , June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained full
Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut
12:46pm, Wednesday, 18'th Jun 2025
Caris Life Sciences' shares jumped nearly 29% in their New York debut on Wednesday, fetching the cancer diagnostic firm a valuation of $7.66 billion and signaling a growing investor appetite for new l
